Enrique Poradosu
Oprichter bij NUVECTIS PHARMA, INC.
Vermogen: 10 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Enrique Poradosu
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 35 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Enrique Poradosu via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer President Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Emory University | College/University | Graduate Degree Corporate Officer/Principal | |
| Ithaca College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Siena College | College/University | Undergraduate Degree Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| Baruch College | College/University | Masters Business Admin Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal General Counsel | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder Director of Finance/CFO | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Medical/Nursing Services | Chairman Director/Board Member | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Chairman Director/Board Member | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Israël | 4 |
| Nederland | 3 |
| Australië | 2 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 14 |
| Finance | 4 |
| Health Services | 4 |
| Commercial Services | 4 |
Operationeel
| Director/Board Member | 191 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 67 |
| Director of Finance/CFO | 55 |
| Undergraduate Degree | 47 |
Sterkste connecties
| Insiders | |
|---|---|
| Uri Ben-Or | 31 |
| J. Buchi | 26 |
| Michael Weiss | 25 |
| Ronald Renaud | 24 |
| Lindsay Rosenwald | 23 |
| Joseph Feczko | 23 |
| Eric Rose | 21 |
| Kevin Cameron | 17 |
| BILL Kessler | 16 |
| Darren Cline | 15 |
| Wyche Fowler | 15 |
| Eric Dobmeier | 14 |
| Daniel Hume | 14 |
| Abraham Ceesay | 13 |
| Ronald Bentsur | 13 |
- Beurs
- Insiders
- Enrique Poradosu
- Bedrijfsconnecties
